Partnership For Cures, operating under the name Cures Within Reach, is located in Chicago, IL. The organization was established in 2005. According to its NTEE Classification (H12) the organization is classified as: Fund Raising & Fund Distribution, under the broad grouping of Medical Research and related organizations. As of 07/2024, Cures Within Reach employed 3 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Cures Within Reach is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 07/2024, Cures Within Reach generated $1.8m in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 7.9% each year. All expenses for the organization totaled $1.6m during the year ending 07/2024. While expenses have increased by 6.0% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2018, Cures Within Reach has awarded 73 individual grants totaling $5,040,951. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2024
Describe the Organization's Mission:
Part 3 - Line 1
TO HELP PATIENTS BY RAISING FUNDS TO FIND VET FINANCE MANAGE PILOT HUMAN CLINICAL TRIALS THAT TEST ALREADY APPROVED DRUGS DEVICES AND
Describe the Organization's Program Activity:
Part 3 - Line 4a
REPURPOSING RESEARCH: IN ITS MAIN AREA OF FOCUS, THE ORGANIZATION CATALYZES CLINICAL TRIALS TESTING APPROVED THERAPIES BY FINDING AND FACILITATING THESE PROOF-OF-CONCEPT CLINICAL TRIALS THAT, WHEN SUC- CESFUL, CATALYZE FOLLOW-ON FUNDING FOR FURTHER TRIALS AND PUBLICATIONS IN ORDER TO ALLOW BROAD PATIENT USE. IN FY 2024:15 NEW CLINICAL REPURPOSING TRIALS WERE SIGNED (IN MATERNAL HEALTH, NEUROLOGY, ONCOLOGY, RARE DISEASES AND OTHER DISEASE AREAS), WHILE 9 CLINICAL TRIALS WERE COMPLETED, AND 35 TRIALS STILL IN PROGRESS - FOR FOR A TOTAL OF 50 ONGOING TRIALS AS OF 7/31/2024.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Barbara Goodman President CEO | Officer | 40 | $195,750 |
Margaret Christie Chair | OfficerTrustee | 2 | $0 |
Matthew Rich Treasurer | OfficerTrustee | 1 | $0 |
Lucy Mancini-Newell Secretary | OfficerTrustee | 1 | $0 |
Kristina Allikmets Director | Trustee | 1 | $0 |
Steve Braun Director | Trustee | 1 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $1,466,673 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $1,466,673 |
Total Program Service Revenue | $0 |
Investment income | $201,885 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $108,738 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $1,777,296 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $665,727 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $335,963 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $200,038 |
Compensation of current officers, directors, key employees. | $40,008 |
Compensation to disqualified persons | $181,108 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $29,806 |
Payroll taxes | $27,245 |
Fees for services: Management | $51,850 |
Fees for services: Legal | $26,551 |
Fees for services: Accounting | $20,358 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $0 |
Advertising and promotion | $0 |
Office expenses | $4,158 |
Information technology | $12,096 |
Royalties | $0 |
Occupancy | $37,629 |
Travel | $0 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $4,070 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $627 |
Insurance | $3,176 |
All other expenses | $0 |
Total functional expenses | $1,607,374 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $0 |
Savings and temporary cash investments | $1,519,133 |
Pledges and grants receivable | $138,366 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $3,602 |
Net Land, buildings, and equipment | $942 |
Investments—publicly traded securities | $3,190,547 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $40,539 |
Total assets | $4,893,129 |
Accounts payable and accrued expenses | $34,282 |
Grants payable | $1,424,492 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $1,458,774 |
Net assets without donor restrictions | $1,129,127 |
Net assets with donor restrictions | $2,305,228 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $4,893,129 |
Over the last fiscal year, Partnership For Cures has awarded $623,238 in support to 10 organizations.
Grant Recipient | Amount |
---|---|
BRIGHAM YOUNG UNIVERSITY PURPOSE: Clinical trialsresearch | $60,000 |
COLORADO STATE UNIVERSITY PURPOSE: Clinical trialsresearch | $16,000 |
CHICAGO ASSOC FOR RESEARCH PURPOSE: Clinical trialsresearch | $75,000 |
UNIVERSITY OF PITTSBURGH PURPOSE: Clinical trialsresearch | $70,000 |
REGENT OF UNIV OF MICHIGAN PURPOSE: Clinical trialsresearch | $60,042 |
TRUSTEES OF UNIV OF IL PURPOSE: Clinical trialsresearch | $81,600 |